CSF YKL-40 Level Predicts the Cognitive Progress of De Novo Parkinson’s Disease (P10-3.013)

To assess the utility of CSF YKL-40 in monitoring cognitive progression in de novo Parkinson’s disease (PD) patients as well as, predicting future cognitive decline, and its investigating potential underlying mechanisms.

Authors

Lingzhi Ma (ORCID: https://orcid.org/0000-0001-8963-0030)

Institutions

Qingdao University (CN)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000211680
Primary Topic: Studies on Chitinases and Chitosanases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

CSF YKL-40 Level Predicts the Cognitive Progress of De Novo Parkinson’s Disease (P10-3.013)

Lingzhi Ma

Apr 7, 2025

Neurology

Studies on Chitinases and Chitosanases

article

CSF YKL-40 Level Predicts the Cognitive Progress of De Novo Parkinson’s Disease (P10-3.013)

Lingzhi Ma

April 7, 2025article en

Abstract

NeurologyVol. 104(7_Supplement_1)

Qingdao University (CN)

Openalex Percentile: Top 94%

Studies on Chitinases and Chitosanases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.